Navigation Links
EquitiesIQ Initiates Coverage of Alliqua, Inc.
Date:1/14/2014

care dressings, and the tissue based wound healing products from Celgene, Alliqua is now positioned to address a spectrum of wounds with a broad line of innovative solutions.

The full Initiation Report is available to download at the EquitiesIQ website. EquitiesIQ will provide ongoing coverage and event-based updates as developments occur.

Free report download: http://equitiesiq.com/reports/alliqua/

About EquitiesIQ

EquitiesIQ publishes and distributes research reports that enhance the visibility of our client companies. Our reports are written by analysts who recognize investors’ desire to understand a business in a way that supports an educated investment decision. To learn more about EquitiesIQ, visit the company's website, http://equitiesiq.com. EquitiesIQ is not a registered investment adviser or broker-dealer.

Important Disclosures and Disclaimers

The research report described in this press release has been prepared by EquitiesIQ, LLC on behalf of Alliqua, Inc. (the “Company”), as part of investor relations services provided to Alliqua by EquitiesIQ. EquitiesIQ has been compensated for preparation of the research report and for future coverage, as fully disclosed in the report. David Moskowitz is the author of the report and the views regarding Alliqua expressed in the report accurately reflect the personal views of Mr. Moskowitz regarding Alliqua and its securities, as of the date of the report.

The research report is not an offer or solicitation to buy or sell the securities of the Alliqua. This report is for information purposes only, and is not intended to (and is provided explicitly on the condition that it not) be used as the sole basis to make any investment decision. Investors should make their own determinations w
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
2. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
3. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
4. Applied Genetics Initiates Commercial Operation
5. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
6. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
7. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
8. ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188
9. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
10. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
11. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 ­ Caris Life ... promise of precision medicine, today announced it has appointed ... a center of excellence site in the Caris Centers ... Levine Cancer Institute is one of the largest ... than 11,000 new cancer patients annually. Derek Raghavan ...
(Date:5/26/2015)... Regenestem Network has announced the grand opening ... Argentina. The clinic will be lead by Silvina Pastrana, ... a multidisciplinary team of medical professionals who specialize in ... office. , The new Regenestem Network members plan ... in cellular therapies, and establish Regenestem protocols to isolate ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 ... and solutions in the human and animal health ... annual Vetericyn® Future Innovators of Agriculture College Scholarship ... school senior who exhibits a passionate commitment to ... , This year’s winners, Alexis Pedrow from ...
(Date:5/26/2015)... and HILDEN, Germany , ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... QIAGEN Clinical Insight ® (QCI™) bioinformatics content ... interpret and report on genomic variants identified in ... for the bioinformatics platform are in oncology, for ...
Breaking Biology Technology:Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 2Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
... -- Micromet, Inc. (Nasdaq: MITI ... the treatment of cancer, inflammation and autoimmune diseases, today ... Christian Itin, will participate in a panel discussion titled ... Markets Healthcare Conference on December 10, 2008. The ...
... based on the products of newborn fibroblasts, will be featured in ... 21st Century Breakthroughs for Biomedical Research series. , ... ... medicine company developing solutions based on the products of newborn fibroblasts, ...
... closures observed in PRECiSE 2 trial under maintenance therapy with ... , HOLLYWOOD, Fla., Dec. 5 Data ... Diseases 2008, the Crohn,s & Colitis Foundation,s Clinical & Research ... severe Crohn,s disease patients who had open fistulas at baseline ...
Cached Biology Technology:Micromet to Present at the RBC Capital Markets Healthcare Conference 2Micromet to Present at the RBC Capital Markets Healthcare Conference 3Micromet to Present at the RBC Capital Markets Healthcare Conference 4Histogen Featured on Economic Report Television Series 2New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 2New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 3New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 4New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 5New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 6New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 7New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 8New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease 9
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/20/2015)... 20, 2015 The announcement comes ... Glenbeigh Records Management (GRM), Ireland,s foremost ... Bank. Having built up an impressive track record of clients ... player within the records management sector in Dubai ... is GCC staffbase and employ a further eight staff members ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... machine can draw your blood, screen it for genetic mutations ... a drug tailor-made for your DNA. That hypothetical drug ... have accumulated over time that can lead to the formation ... Health has tapped Viterbi professor Andrea Armani to develop a ...
... award up to $64 million over five years to ... that have the potential for extraordinary impact. ... allows investigators to sidestep conventional stumbling blocks they often ... as the need for preliminary data or a restriction ...
... Institutes of Health (NIH) has awarded $11.5 million to ... Institute of Technology (Caltech) for the creation of a ... centercalled the Center for the X-ray Structure Determination of ... by the NIH to "solve the structures of these ...
Cached Biology News:Fighting cancers by tagging their triggers 2NIH awards $11.5 million for new Caltech-led membrane-protein center 2
... Mouse polyclonal antibody raised against ... Immunogen: PPP4C ... a.a) partial recombinant protein with ... Accession Number: NM_002720 ...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
...
... array sample elements. , , ,Includes:, , , ... PBS (10X): 50 ml , INDIA HisProbe HRP: 0.2 ... 10% Tween-20: 2 x 10 ml ampules , SuperSignal ... SuperSignal West Pico Stable Peroxide: 2 x 25 ...
Biology Products: